| IC provides strategic |
| knowledge across industry segments |
The critical success factor of strategy implementation is a deep understanding of the market and its past, current and future drivers. Our core focus in the life sciences industry allows us to be specialists, and therefore more accurately serve your needs.
| Industry segment strategy: |
How to maximize the use of your core assets to leverage market segment arbitrages in the life sciences industry
- Based on our collective experience, IC demonstrated its clinical and market expertise by working with pharmaceutical, biotech, medical devices, diagnostic (chemical and imaging), and health services corporations
How to build on clinical knowledge and behaviors to create new competitive advantages
- Based on its medical and clinical experience, IC demonstrated its understanding of the life-sciences marketplace to help corporations to position their businesses in the following therapeutic areas: oncology, inflammation, pain, cardiovascular and metabolic diseases infectious diseases, respiratory, central nervous system, and hematology.
How to use knowledge on life-science customers’ interactions to deliver superior value to a healthcare corporation
- Based on expertise in operating with / as care providers, payers and patients, IC demonstrated its superior knowledge to anticipate market unmet needs and consequently solutions to bridge gaps that are valuable for the different interrelated audiences.
|
|
 IDIS & CHeSS blend expertise to create a new consulting firm dedicated on transcontinental business development services, including Marketing and Sales strategy and Operations.
IC assists innovative companies in the healthcare and information technology markets in their overseas expansion efforts. Acting as a guide, IC provides customized market entry strategies, consulting, sales and marketing. |
|
